RxDoctor Payments DataLook up a doctor →

Anthony Blalock, MD

Nephrology · Lafayette, LANPI 1124037726

Payments from drug & device makers

$349,886in general payments, 2019–2025

Across 516 payments — averaging $678.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$349K
  • Travere Therapeutics, Inc.$250
  • Coloplast$178
  • Akebia Therapeutics Inc$128
  • Daiichi Sankyo Inc.$57
  • Mallinckrodt Hospital Products Inc.$45
  • plus $134 from 6 others

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$349,886 in reported general payments places this provider in the 95th percentile of 206 nephrology providers in Louisiana.

See all nephrology providers in Louisiana

Medicare billing

Part B allowed, 2024
$379,244
Medicare patients
609
Services billed
3,306

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →